Clinical Trial Update: Safety and Immunogenicity of Recombinant Zoster Vaccine for Transplant Recipients [NA]

View source ↗

Summary

A clinical trial update evaluating the safety and immunogenicity of the recombinant zoster vaccine in immunosuppressed transplant recipients, currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Zoster

Drugs mentioned

• Shingrix (recombinant zoster vaccine, adjuvanted)

Snippet

Sponsor: Central Adelaide Local Health Network Incorporated | Conditions: Immunosuppression, Vaccine Response Impaired | NA | Status: RECRUITING